Nathan Johnson, CEO of Vern Bioanalytics, discusses the challenges of treating cancer and the potential of cannabis in cancer research. He explains that cancer is a result of cells not receiving the right signals to stop dividing and that there are various mechanisms involved in tumor growth.
Nathan emphasizes the importance of understanding cannabis and its complex components in order to effectively use it as a tool in cancer treatment. He also mentions that while some studies have shown the positive effects of cannabis on cancer cells, there are cases where it can actually make the tumor grow faster. Nathan shares his personal observations and highlights the need for further research to understand why cannabis works for some individuals but not for others.
Nathan Johnson, Ph.D., is the co-founder and CEO of Vern Bioanalytics in Massachusetts. With a background in the pharmaceutical sector, Nathan has extensive experience in analyzing vast amounts of data to find patterns and make a difference in the field of cancer research. He is passionate about using AI and cannabis to tackle complex diseases and improve patient outcomes.